EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs

by Elena Iemma | Oct 24, 2024 | News

PROVIDENCE, R.I., Oct. 24, 2024 /PRNewswire/ — EpiVax, Inc. and CUBRC, Inc. announce today that they have been awarded a two-year, $2 million contract (#75F40124C00094) from the Office of Generic Drugs (OGD) of the Food and Drug...

ISV 2022 Computational Vaccinology Pre-Conference Workshop September 17th, 2022 ***Updated with Pictures******

by Elena Iemma | Jul 22, 2022 | Events

A big thank you to everyone that came out to the pre-conference Computational Vaccinology workshop at ISV! Agenda and pictures from the day below. ISV 2022 Computational Vaccinology Conference Workshop Saturday September 17, 9-4 pm ET Delta Hotels Québec 690 Boul René...

AAPS BPABC Community Presentation: In silico Immunogenicity Prediction for Protein and Peptide Therapeutics

by Elena Iemma | Mar 11, 2021 | Events, Webinars

Aimee Mattei, Senior Project Manager on our Bioinformatics team, will be presenting to the AAPS BPABC(biopharmaceutical product attributes and biological consequences) Community on March 18th at 12pm ET. You’ll need to join the group to register, membership is...

FDA Webinar: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling

by Elena Iemma | Jan 26, 2021 | Events, Webinars

The FDA hosted a virtual workshop January 26, 2021 to provide updates and foster discussions around non-clinical assays for comparative immunogenicity risk assessment of generic peptide products. EpiVax CEO/CSO, Annie De Groot, presented an update on EpiVax’s...

European Workshop on Protein Aggregation and Immunogenicity January 28th-29th, 2019 (Updated)

by Annie De Groot | Jan 2, 2019 | Events

4th European Workshop on Protein Aggregation and Immunogenicity Monday, January 28 – Tuesday, January 29 Austria Trend Comfort Hotel Salzburg West Bundesstraße 4 5073 Salzburg-Wals, Austria Thank you to everyone who attended EpiVax’s presentation at the...